• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient.一名所罗门群岛患者的铁转运蛋白1新突变与血色素沉着症相关。
Gut. 2003 Aug;52(8):1215-7. doi: 10.1136/gut.52.8.1215.
2
Genetic haemochromatosis: genes and mutations associated with iron loading.遗传性血色素沉着症:与铁负荷相关的基因和突变
Best Pract Res Clin Haematol. 2002 Jun;15(2):261-76. doi: 10.1016/s1521-6926(02)90207-0.
3
HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.印度原发性血色素沉着症患者不存在HFE、铁调素和铁转运蛋白基因突变。
Natl Med J India. 2006 Jan-Feb;19(1):20-3.
4
Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.
Blood. 2002 Jul 15;100(2):692-4. doi: 10.1182/blood.v100.2.692.
5
Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man.两个新的 SLC40A1 和 HFE 基因突变与一名西班牙男性的铁过载有关。
Eur J Haematol. 2011 Mar;86(3):260-4. doi: 10.1111/j.1600-0609.2010.01565.x. Epub 2011 Jan 11.
6
Compound heterozygous C282Y/Q283P and Q283P/H63D mutations in haemochromatosis.血色素沉着症中的复合杂合子C282Y/Q283P和Q283P/H63D突变
Br J Haematol. 2015 Nov;171(4):650-1. doi: 10.1111/bjh.13417. Epub 2015 Apr 8.
7
Review article: the genetic basis of haemochromatosis.综述文章:血色素沉着症的遗传基础。
Aliment Pharmacol Ther. 2007 Aug 1;26(3):331-42. doi: 10.1111/j.1365-2036.2007.03387.x.
8
SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype.SLC40A1基因c.1402G→A导致异常剪接,铁转运蛋白在甘氨酸330之后截短,并产生常染色体显性遗传性血色素沉着症表型。
Acta Haematol. 2007;118(4):237-41. doi: 10.1159/000112830. Epub 2007 Dec 21.
9
[From gene to disease; HFE-mutations in primary haemochromatosis].[从基因到疾病;原发性血色素沉着症中的HFE突变]
Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):652-6.
10
[Diagnosis and treatment of genetic haemochromatosis].[遗传性血色素沉着症的诊断与治疗]
Ugeskr Laeger. 2013 Apr 15;175(16):1109-12.

引用本文的文献

1
Diagnosis and Management of Non-HFE Hemochromatosis, Ferroportin Disease, and Rare Hereditary Iron-Loading Disorders.非HFE型血色素沉着症、铁转运蛋白病及罕见遗传性铁过载疾病的诊断与管理
Adv Exp Med Biol. 2025;1480:131-143. doi: 10.1007/978-3-031-92033-2_10.
2
Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment.铁死亡与非编码RNA:探索肺癌治疗中的机制
Front Cell Dev Biol. 2025 Feb 26;13:1522873. doi: 10.3389/fcell.2025.1522873. eCollection 2025.
3
Iron Metabolism in Ferroptosis.铁死亡中的铁代谢
Front Cell Dev Biol. 2020 Oct 7;8:590226. doi: 10.3389/fcell.2020.590226. eCollection 2020.
4
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.亚铁转运蛋白结合血红素肽的结构揭示了铁稳态的机制。
Nature. 2020 Oct;586(7831):807-811. doi: 10.1038/s41586-020-2668-z. Epub 2020 Aug 19.
5
Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.使用邻近连接分析检测人肝细胞系中铁蛋白的二聚化。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20191499.
6
Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.铁转运蛋白病二十年:已发表的临床、生化、分子及功能特征综述或更新
Pharmaceuticals (Basel). 2019 Sep 9;12(3):132. doi: 10.3390/ph12030132.
7
Ferroportin disease mutations influence manganese accumulation and cytotoxicity.铁蛋白病突变影响锰的积累和细胞毒性。
FASEB J. 2019 Feb;33(2):2228-2240. doi: 10.1096/fj.201800831R. Epub 2018 Sep 24.
8
Ferroportin disease: pathogenesis, diagnosis and treatment.铁蛋白病:发病机制、诊断与治疗。
Haematologica. 2017 Dec;102(12):1972-1984. doi: 10.3324/haematol.2017.170720. Epub 2017 Nov 3.
9
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.铁蛋白病:临床与分子研究的系统荟萃分析。
J Hepatol. 2010 Nov;53(5):941-9. doi: 10.1016/j.jhep.2010.05.016. Epub 2010 Jul 17.
10
Genetic mechanisms and modifying factors in hereditary hemochromatosis.遗传性血色素沉着症的遗传机制和修饰因子。
Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):50-8. doi: 10.1038/nrgastro.2009.201. Epub 2009 Nov 17.

本文引用的文献

1
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.突变抗菌肽铁调素与严重青少年血色素沉着症相关。
Nat Genet. 2003 Jan;33(1):21-2. doi: 10.1038/ng1053. Epub 2002 Dec 9.
2
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).与铁转运蛋白基因(SLC11A3)编码区三碱基对缺失相关的遗传性高铁蛋白血症和网状内皮系统铁过载。
Br J Haematol. 2002 Nov;119(2):539-46. doi: 10.1046/j.1365-2141.2002.03946.x.
3
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.铁转运蛋白1的缬氨酸缺失:4型血色素沉着症中的常见突变。
Blood. 2002 Jul 15;100(2):733-4. doi: 10.1182/blood-2002-03-0693.
4
Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).常染色体显性遗传性网状内皮细胞铁过载,与铁转运蛋白1基因(SLC11A3)中的3个碱基对缺失相关。
Blood. 2002 Jul 15;100(2):695-7. doi: 10.1182/blood-2001-11-0132.
5
Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.
Blood. 2002 Jul 15;100(2):692-4. doi: 10.1182/blood.v100.2.692.
6
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.常染色体显性遗传性血色素沉着症与铁转运蛋白(SLC11A3)基因突变有关。
J Clin Invest. 2001 Aug;108(4):619-23. doi: 10.1172/JCI13468.
7
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.溶质载体家族11成员3(SLC11A3)中的一种突变与常染色体显性遗传性血色素沉着症相关。
Nat Genet. 2001 Jul;28(3):213-4. doi: 10.1038/90038.
8
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation.一种新的十二指肠铁调节转运蛋白IREG1,参与铁从基底外侧向循环系统的转运。
Mol Cell. 2000 Feb;5(2):299-309. doi: 10.1016/s1097-2765(00)80425-6.
9
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.基因TFR2在一种新的定位到7q22的血色素沉着症中发生突变。
Nat Genet. 2000 May;25(1):14-5. doi: 10.1038/75534.
10
A novel mammalian iron-regulated protein involved in intracellular iron metabolism.一种参与细胞内铁代谢的新型哺乳动物铁调节蛋白。
J Biol Chem. 2000 Jun 30;275(26):19906-12. doi: 10.1074/jbc.M000713200.

一名所罗门群岛患者的铁转运蛋白1新突变与血色素沉着症相关。

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient.

作者信息

Arden K E, Wallace D F, Dixon J L, Summerville L, Searle J W, Anderson G J, Ramm G A, Powell L W, Subramaniam V N

机构信息

Membrane Transport Laboratory, The Queensland Institute of Medical Research, Brisbane, Australia.

出版信息

Gut. 2003 Aug;52(8):1215-7. doi: 10.1136/gut.52.8.1215.

DOI:10.1136/gut.52.8.1215
PMID:12865285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1773758/
Abstract

BACKGROUND

A severe form of iron overload with the clinicopathological features of haemochromatosis inherited in an autosomal dominant manner has been described in the Solomon Islands. The genetic basis of the disorder has not been identified. The disorder has similarities to type 4 haemochromatosis, which is caused by mutations in ferroportin1.

AIMS

The aims of this study were to identify the genetic basis of iron overload in a patient from the Solomon Islands.

PATIENT AND METHODS

Genomic DNA was isolated from peripheral blood leucocytes of a Solomon Islands man with severe iron overload. The entire coding region and splice sites of the ferroportin1 gene was sequenced.

RESULTS AND CONCLUSIONS

A novel missense mutation (431A>C; N144T) was identified in exon 5 of the ferroportin1 gene. A novel restriction endonuclease based assay which identifies both the N144T and N144H mutations was developed which will simplify the diagnosis and screening of patients for iron overload in the Solomon Islands and other populations. This is the first identified mutation associated with haemochromatosis in the Solomon Islands population.

摘要

背景

在所罗门群岛,已描述了一种以常染色体显性方式遗传的具有血色素沉着症临床病理特征的严重铁过载形式。该病症的遗传基础尚未确定。该病症与4型血色素沉着症相似,后者由铁转运蛋白1的突变引起。

目的

本研究的目的是确定一名来自所罗门群岛患者铁过载的遗传基础。

患者与方法

从一名患有严重铁过载的所罗门群岛男性的外周血白细胞中分离基因组DNA。对铁转运蛋白1基因的整个编码区和剪接位点进行测序。

结果与结论

在铁转运蛋白1基因的第5外显子中鉴定出一个新的错义突变(431A>C;N144T)。开发了一种基于新型限制性内切酶的检测方法,可鉴定N144T和N144H突变,这将简化所罗门群岛及其他人群中铁过载患者的诊断和筛查。这是在所罗门群岛人群中首次鉴定出的与血色素沉着症相关的突变。